热门
Common activation mechanism of class A GPCRs
文献类型:期刊论文
作者 | Zhou, Qingtong5; Yang, Dehua4,6,7![]() |
刊名 | ELIFE
![]() |
出版日期 | 2019-12-19 |
卷号 | 8页码:31 |
ISSN号 | 2050-084X |
DOI | 10.7554/eLife.50279 |
通讯作者 | Babu, M. Madan(madanm@mrc-lmb.cam.ac.uk) ; Wang, Ming-Wei(mwwang@simm.ac.cn) ; Zhao, Suwen(zhaosw@shanghaitech.edu.cn) |
英文摘要 | Class A G-protein-coupled receptors (GPCRs) influence virtually every aspect of human physiology. Understanding receptor activation mechanism is critical for discovering novel therapeutics since about one-third of all marketed drugs target members of this family. GPCR activation is an allosteric process that couples agonist binding to G-protein recruitment, with the hallmark outward movement of transmembrane helix 6 (TM6). However, what leads to TM6 movement and the key residue level changes of this movement remain less well understood. Here, we report a framework to quantify conformational changes. By analyzing the conformational changes in 234 structures from 45 class A GPCRs, we discovered a common GPCR activation pathway comprising of 34 residue pairs and 35 residues. The pathway unifies previous findings into a common activation mechanism and strings together the scattered key motifs such as CWxP, DRY, Na+ pocket, NPxxY and PIF, thereby directly linking the bottom of ligand-binding pocket with G-protein coupling region. Site-directed mutagenesis experiments support this proposition and reveal that rational mutations of residues in this pathway can be used to obtain receptors that are constitutively active or inactive. The common activation pathway provides the mechanistic interpretation of constitutively activating, inactivating and disease mutations. As a module responsible for activation, the common pathway allows for decoupling of the evolution of the ligand binding site and G-protein-binding region. Such an architecture might have facilitated GPCRs to emerge as a highly successful family of proteins for signal transduction in nature. |
WOS关键词 | PROTEIN-COUPLED RECEPTOR ; SERIAL FEMTOSECOND CRYSTALLOGRAPHY ; STABILIZED ACTIVE STATE ; CRYO-EM STRUCTURE ; STRUCTURAL INSIGHTS ; CRYSTAL-STRUCTURE ; OPIOID RECEPTOR ; ALLOSTERIC COMMUNICATION ; CONFORMATIONAL-CHANGES ; OLFACTORY RECEPTORS |
资助项目 | Medical Research Council[MC_U105185859] ; Novo Nordisk-CAS Research[NNCAS-2017-1-CC] ; Young Talent Program of Shanghai ; Shanghai Science and Technology Development Fund[16ZR1448500] ; Shanghai Science and Technology Development Fund[16ZR1407100] ; National Natural Science Foundation of China[21704064] ; National Natural Science Foundation of China[81573479] ; National Natural Science Foundation of China[81773792] ; National Natural Science Foundation of China[31971178] ; National Natural Science Foundation of China[81872915] ; National Mega R&D Program for Drug Discovery[2018ZX09735-001] ; National Mega R&D Program for Drug Discovery[2018ZX09711002-002-005] ; National Key R&D Program of China[2016YFC0905900] ; National Key R&D Program of China[2018YFA0507000] ; National Institute of General Medical Sciences[GM130142] |
WOS研究方向 | Life Sciences & Biomedicine - Other Topics |
语种 | 英语 |
WOS记录号 | WOS:000506841000001 |
出版者 | ELIFE SCIENCES PUBLICATIONS LTD |
源URL | [http://119.78.100.183/handle/2S10ELR8/282481] ![]() |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Babu, M. Madan; Wang, Ming-Wei; Zhao, Suwen |
作者单位 | 1.Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA USA 2.MRC Lab Mol Biol, Cambridge, England 3.Fudan Univ, Sch Pharm, Shanghai, Peoples R China 4.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai, Peoples R China 5.ShanghaiTech Univ, iHuman Inst, Shanghai, Peoples R China 6.Univ Chinese Acad Sci, Beijing, Peoples R China 7.Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai, Peoples R China 8.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China 9.Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA |
推荐引用方式 GB/T 7714 | Zhou, Qingtong,Yang, Dehua,Wu, Meng,et al. Common activation mechanism of class A GPCRs[J]. ELIFE,2019,8:31. |
APA | Zhou, Qingtong.,Yang, Dehua.,Wu, Meng.,Guo, Yu.,Guo, Wangjing.,...&Zhao, Suwen.(2019).Common activation mechanism of class A GPCRs.ELIFE,8,31. |
MLA | Zhou, Qingtong,et al."Common activation mechanism of class A GPCRs".ELIFE 8(2019):31. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。